Global Respiratory Inhalers Market, by Product Type, Application, Technology, and Region - Trends and Analysis to 2025

1. Global Respiratory Inhalers Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

2. REPORT DESCRIPTION Global Respiratory Inhalers Market – Overview Respiratory diseases such as bronchitis, asthma, allergic rhinitis, pneumonia and sinusitis can significantly curtail the physical activities of the individual. The symptoms associated with both mild and severe manifestations of these respiratory conditions include coughing, wheezing, chest pain, respiratory distress, shortness of breath, congestion, and even death in severe cases. These conditions lead to substantial morbidity and causes large cost of burden to the society. Increasing air pollution can severely affect respiratory health of children as well as adults. Various studies conducted have shown the ill effects of air pollution that can exacerbate existing respiratory conditions such as asthma, COPD, and upper airway allergies. According to the Forum of International Respiratory Societies, in 2013, young children and infants were especially susceptible to respiratory diseases. Around 9.0 million children under the age of 5 years die per year and the common thing in them is the presence of lung diseases. Increase in evidences through such studies suggests that the exposure to certain type of air pollutants contributes to the onset of asthma. However, studies related to the exacerbation of pre-acquired and existing asthma are more prevalent as they provide favorable conditions to study.

3. REPORT DESCRIPTION Global Respiratory Inhalers Market – Taxonomy ●In September, GlaxoSmithKline plc, received approval for Trelegy Ellipta. Trelegy Ellipta, is the first once-daily use inhaler triple therapy (i.e. combination of 3 active molecules in a single inhaler) for the treatment of Chronic Obstructive Pulmonary Disease (COPD). ●In April, 2016, AstraZeneca received approval for Bevespi Aerosphere, the first product which uses AstraZeneca’s Co-Suspension Technology. The technology enables more than one medicine delivery from a single MDI. ●In 2010, around 115,000 patients were hospitalized due to sever chronic obstructive pulmonary disease, which cost the NHS around US$ 367.85 Mn and is expected to increase over the forecast period. Sandoz launched an innovative respiratory inhaler AirFluSal Forspiro in the UK in 2015, to capitalize on the highly lucrative market in the region. Get PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/227

4. REPORT DESCRIPTION Global Respiratory Inhalers Market – Key Players • Beximco Pharmaceuticals Ltd., • Boehringer Ingelheim GmbH, • Cipla Ltd., GlaxoSmithKline plc, • Koninklijke Philips N.V., Merck & Co., Inc., • OMRON Healthcare Europe B.V., • PARI Medical Holding and Teva Pharmaceutical Industries Ltd. Read More @ https://www.coherentmarketinsights.com/market-insight/respiratory-inhalers-market-227

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH SYNDICATED RESEARCH INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools.

7. ABOUT US RESEARCH SOLUTIONS KEY STATS GLOBAL REPORTS FEASIBILITY STUDIES 100 Insights Published Per Year + 150+ COUNTRY ANALYSIS CONSULT PROJECTS Consulting Projects Till Date 125+ SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT Clients Worldwide Per Year 110+ TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702